OPTIMUM USE CONDITIONS
For maximum benefit the PREVENA PLUS™ Incision Management System should be applied
immediately post surgery to clean surgically closed wounds. It is to be continuously applied for a
minimum of two days up to a maximum of seven days. It can transition home with the patient.
The PREVENA PLUS™ Incision Management System will not be effective in addressing complications
associated with:
•
ischemia to the incision or incision area
•
untreated or inadequately treated infection
•
inadequate hemostasis of the incision
•
cellulitis of the incision area
The PREVENA PLUS™ Incision Management System should not be used to treat open or dehisced
surgical wounds.
The V.A.C.® Therapy System should be considered for treatment of these wounds.
Consider using the smallest available canister for the selected V.A.C.® Therapy Unit.
The PREVENA PLUS™ Incision Management System should be used with caution in the following
patients:
•
patients with fragile skin surrounding the incision as they may experience skin or tissue
damage upon removal of the PREVENA PLUS™ Dressing
•
patients who are at an increased risk of bleeding from the incision associated with the use of
anticoagulants and/or platelet aggregation inhibitors
CONTRAINDICATION
•
sensitivity to silver
WARNINGS
The PREVENA PLUS™ Incision Management System is not intended to manage open or
dehisced wounds.
DO NOT use with V.A.C. VERAFLO™ Therapy (Instillation) provided by the V.A.C.ULTA™ Therapy
Unit. Instillation into the incision site may result in pooling of fluid which may result in
maceration.
Bleeding: Before applying the PREVENA PLUS™ Incision Management System to patients who
are at risk of bleeding complications due to the operative procedure or concomitant therapies
and/or co-morbidities, ensure that hemostasis has been achieved and all tissue planes have been
approximated. If active bleeding develops suddenly or in large amounts during therapy, or if frank
blood is seen in the tubing or in the canister, the patient should leave the PREVENA PLUS™ Dressing
in place, turn off the therapy unit and seek immediate emergency medical assistance.
Infected Wounds: As with any wound treatment, clinicians and patients/caregivers should
frequently monitor the patient's wound, periwound tissue and exudate for signs of infection or
other complications. Some signs of infection are fever, tenderness, redness, swelling, itching, rash,
increased warmth in the wound or periwound area, purulent discharge or strong odor. Infection
can be serious, and can lead to complications such as pain, discomfort, fever, gangrene, toxic shock,
septic shock and/or fatal injury. Some signs or complications of systemic infection are nausea,
vomiting, diarrhea, headache, dizziness, fainting, sore throat with swelling of the mucus membranes,
disorientation, high fever, refractory and/or orthostatic hypotension or erythroderma (a sunburn-like
6